Go Pro
→ Do NOT Buy SpaceX – Do This Instead (From Stansberry Research) (Ad)tc pixel Free MDRX Stock Alerts

Veradigm (MDRX) Financials

Veradigm logo
$5.10 +0.10 (+1.90%)
As of 07/2/2026 09:35 AM Eastern
Compare
Annual Income Statements for Veradigm

Annual Income Statements for Veradigm

This table shows Veradigm's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -66 -2.23 -26 -196 364 -182 696 140 -86 49 -292
Consolidated Net Income / (Loss)		 -66 -2.06 3.03 -154 408 -183 696 140 -86 49 -292
Net Income / (Loss) Continuing Operations		 -66 -2.06 31 -185 -43 -238 -28 128 -19 49 -284
Total Pre-Tax Income 		-68 0.57 32 -190 -62 -282 -13 158 -63 60 -215
Total Operating Income		 -39 32 68 12 -168 -100 7.94 77 -27 35 -195
Total Gross Profit		 546 581 601 633 621 610 264 282 308 342 302
Total Revenue		 1,378 1,386 1,386 1,498 1,618 1,633 556 577 588 626 594
Operating Revenue		 1,378 1,386 1,386 1,498 1,618 1,633 556 577 588 626 594
Total Cost of Revenue		 832 806 785 865 996 1,022 292 295 280 284 292
Operating Cost of Revenue		 832 806 785 865 996 1,022 292 295 280 284 292
Total Operating Expenses		 585 549 534 620 790 710 256 206 336 293 492
Selling, General & Admin Expense		 359 339 335 401 433 401 156 112 169 201 269
Research & Development Expense		 193 185 179 202 259 245 79 84 98 97 108
Amortization Expense		 31 23 16 17 27 27 12 9.28 61 8.74 11
Impairment Charge		 2.39 1.54 4.65 0.00 72 37 10 0.53 7.55 0.18 108
Other Special Charges / (Income)		 - - - - - - - - 0.00 -14 -5.00
Total Other Income / (Expense), net		 -29 -31 -36 -203 106 -182 -21 81 -36 11 -25
Interest Expense		 29 31 29 38 51 43 34 13 6.35 5.29 33
Interest & Investment Income		 -0.40 -2.10 -7.50 -164 -15 0.01 16 -3.40 -2.67 17 16
Other Income / (Expense), net		 0.77 2.18 0.83 -0.51 172 -139 -1.93 97 -27 -0.59 -8.23
Income Tax Expense		 -1.66 2.63 0.31 -5.51 -19 -43 15 30 -44 11 69
Other Gains / (Losses), net		 - - - - - - - - -1.14 -0.30 -7.18
Net Income / (Loss) Discontinued Operations		 - 0.00 -28 30 451 56 724 12 -66 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 0.17 0.15 -1.57 -4.53 -0.42 - - 0.00 0.00 -0.04
Basic Earnings per Share		 ($0.37) ($0.01) ($0.14) ($1.09) $2.07 ($1.10) $4.37 $1.07 ($0.77) $0.46 ($2.70)
Diluted Earnings per Share		 ($0.37) ($0.01) ($0.14) ($1.09) $2.07 ($1.10) $4.37 $1.01 ($0.77) $0.41 ($2.70)

Quarterly Income Statements for Veradigm

This table shows Veradigm's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022
Period end date 9/30/2022 12/31/2022
Net Income / (Loss) Attributable to Common Shareholders		 15 -60
Consolidated Net Income / (Loss)		 15 -60
Net Income / (Loss) Continuing Operations		 11 -53
Total Pre-Tax Income 		25 -87
Total Operating Income		 25 -53
Total Gross Profit		 83 72
Total Revenue		 152 143
Operating Revenue		 152 143
Total Cost of Revenue		 68 71
Operating Cost of Revenue		 68 71
Total Operating Expenses		 58 125
Selling, General & Admin Expense		 33 36
Research & Development Expense		 24 28
Amortization Expense		 2.24 54
Total Other Income / (Expense), net		 -0.21 -34
Interest Expense		 1.25 1.09
Interest & Investment Income		 -0.62 -7.50
Other Income / (Expense), net		 1.66 -25
Income Tax Expense		 14 -35
Net Income / (Loss) Discontinued Operations		 3.60 -7.12
Basic Earnings per Share		 $0.13 ($0.54)
Weighted Average Basic Shares Outstanding		 109.26M 0.00
Diluted Earnings per Share		 $0.12 ($0.52)
Weighted Average Diluted Shares Outstanding		 109.26M 0.00
Weighted Average Basic & Diluted Shares Outstanding		 109.26M 0.00

Annual Cash Flow Statements for Veradigm

This table details how cash moves in and out of Veradigm's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -9.78 64 -20 66 22 -47 402 -348 256 -1.30 -152
Net Cash From Operating Activities		 103 212 269 279 68 46 -104 -77 117 100 -20
Net Cash From Continuing Operating Activities		 103 212 234 225 -1.79 15 31 114 140 100 -20
Net Income / (Loss) Continuing Operations		 -66 -2.06 31 -185 -43 -238 -28 128 -20 49 -292
Consolidated Net Income / (Loss)		 -66 -2.06 3.03 -154 408 -183 696 140 -86 49 -292
Net Income / (Loss) Discontinued Operations		 - - -28 30 451 56 724 12 -66 0.00 0.00
Depreciation Expense		 174 161 136 157 184 198 87 73 114 53 46
Amortization Expense		 - - - 0.00 0.00 - - - 2.30 1.83 12
Non-Cash Adjustments To Reconcile Net Income		 46 38 53 205 -60 228 -145 -67 77 30 170
Changes in Operating Assets and Liabilities, net		 -50 14 14 48 -83 -172 116 -20 -33 -34 44
Net Cash From Discontinued Operating Activities		 - - 35 54 70 31 -134 -190 -23 0.00 0.00
Net Cash From Investing Activities		 -109 -289 -1,154 -413 248 -161 1,614 -13 585 -88 -126
Net Cash From Continuing Investing Activities		 -109 -289 -245 -332 480 -150 1,682 25 598 -88 -126
Purchase of Property, Plant & Equipment		 -67 -68 -124 -157 -134 -120 -45 -41 -32 -29 -30
Acquisitions		 -20 -9.37 -100 -170 -177 -23 0.00 0.00 -32 0.01 -107
Purchase of Investments		 -22 -216 -21 -5.61 -17 -8.24 -7.10 -2.42 -9.93 -74 -14
Divestitures		 - - 0.00 0.00 808 1.04 1,735 69 670 0.00 0.00
Sale and/or Maturity of Investments		 0.05 - - - 0.00 - - - 2.50 15 26
Net Cash From Discontinued Investing Activities		 - - -909 -81 -232 -11 -68 -38 -13 0.00 0.00
Net Cash From Financing Activities		 -4.28 142 865 199 -293 67 -1,108 -259 -446 -12 -6.65
Net Cash From Continuing Financing Activities		 -4.28 142 -34 168 -442 67 -1,108 -259 -446 -12 -6.65
Repayment of Debt		 -97 -239 -156 -138 -714 -225 -1,667 -75 -200 0.00 0.00
Repurchase of Common Equity		 0.00 0.00 -121 -12 -139 -111 -334 -417 -234 0.00 0.00
Issuance of Debt		 102 284 250 325 431 497 904 250 22 0.00 0.00
Other Financing Activities, net		 -10 -6.42 -7.19 -7.27 -9.47 -25 -6.03 -14 -33 -12 -6.65
Other Net Changes in Cash		 - - -0.53 0.86 - 0.20 -0.05 0.03 0.45 0.00 0.00
Cash Interest Paid		 - - - - - - - - 2.80 1.86 2.17
Cash Income Taxes Paid		 - - - - - - - - 47 19 14

Quarterly Cash Flow Statements for Veradigm

This table details how cash moves in and out of Veradigm's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022
Period end date 9/30/2022 12/31/2022
Net Change in Cash & Equivalents		 -20 -55
Net Cash From Operating Activities		 28 20
Net Cash From Continuing Operating Activities		 42 20
Net Income / (Loss) Continuing Operations		 11 -53
Consolidated Net Income / (Loss)		 15 -60
Net Income / (Loss) Discontinued Operations		 3.60 -7.12
Depreciation Expense		 14 74
Non-Cash Adjustments To Reconcile Net Income		 5.21 56
Changes in Operating Assets and Liabilities, net		 12 -57
Net Cash From Discontinued Operating Activities		 -14 -0.02
Net Cash From Investing Activities		 -9.25 -19
Net Cash From Continuing Investing Activities		 -9.25 -21
Purchase of Property, Plant & Equipment		 -8.17 -4.18
Acquisitions		 - -7.88
Purchase of Investments		 -1.09 -8.59
Net Cash From Discontinued Investing Activities		 - 2.11
Net Cash From Financing Activities		 -38 -58
Net Cash From Continuing Financing Activities		 -38 -69
Repurchase of Common Equity		 -34 -57
Issuance of Debt		 - -0.69
Other Financing Activities, net		 -4.80 -11
Net Cash From Discontinued Financing Activities		 - 12

Annual Balance Sheets for Veradigm

This table presents Veradigm's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 2,464 2,682 3,832 4,230 3,181 3,206 2,918 2,311 1,505 1,573 1,352
Total Current Assets		 487 538 604 857 859 841 1,153 649 680 699 546
Cash & Equivalents		 53 117 96 119 174 130 531 134 447 447 294
Accounts Receivable		 332 328 405 493 465 424 347 120 119 111 108
Prepaid Expenses		 102 94 103 106 142 144 136 52 56 54 53
Other Current Assets		 - - - 0.00 66 93 107 65 57 87 91
Plant, Property, & Equipment, net		 146 126 149 135 122 88 72 18 9.46 0.00 0.00
Total Noncurrent Assets		 1,831 2,018 3,079 3,238 2,201 2,277 1,692 1,644 816 874 807
Long-Term Investments		 1.31 0.00 149 - - - - - - 98 99
Goodwill		 1,201 1,223 1,924 1,293 1,374 974 975 498 533 532 521
Intangible Assets		 490 433 905 630 641 590 480 231 164 145 151
Noncurrent Deferred & Refundable Income Taxes		 1.98 2.30 2.79 4.57 5.04 5.70 5.79 0.00 37 66 1.17
Other Noncurrent Operating Assets		 138 360 98 147 181 279 232 98 81 32 35
Total Liabilities & Shareholders' Equity		 2,464 2,682 3,832 4,230 3,181 3,206 2,918 2,311 1,505 1,573 1,352
Total Liabilities		 1,180 1,263 2,171 2,639 1,601 1,921 1,251 951 487 498 548
Total Current Liabilities		 521 513 667 890 798 1,211 935 488 230 446 422
Short-Term Debt		 27 13 27 29 20 364 - - - 205 155
Accounts Payable		 71 60 126 86 73 103 36 2.17 31 21 31
Accrued Expenses		 79 62 86 78 107 270 100 63 67 52 52
Current Deferred Revenue		 293 316 364 479 467 336 335 88 90 113 121
Current Employee Benefit Liabilities		 51 62 64 83 100 66 119 30 36 27 30
Other Current Liabilities		 - - - - 0.00 22 22 6.13 6.61 27 33
Total Noncurrent Liabilities		 659 750 1,504 1,749 803 710 317 462 257 52 126
Long-Term Debt		 539 612 1,295 907 648 551 168 350 200 0.00 72
Other Noncurrent Operating Liabilities		 75 94 40 90 81 124 127 51 57 52 54
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,284 1,419 1,273 1,160 1,580 1,285 1,666 1,360 1,018 1,074 804
Total Preferred & Common Equity		 1,284 1,408 1,232 1,121 1,551 1,285 1,666 1,360 1,018 1,074 804
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 1,284 1,408 1,232 1,121 1,551 1,285 1,666 1,360 1,018 1,074 804
Common Stock		 1,752 1,792 1,793 1,784 1,884 1,910 1,906 1,965 1,928 1,931 1,952
Retained Earnings		 -188 -190 -187 -338 133 -49 633 720 646 695 403
Treasury Stock		 -278 -190 -311 -323 -461 -571 -871 -1,322 -1,556 -1,551 -1,551
Accumulated Other Comprehensive Income / (Loss)		 -1.98 -4.24 -62 -1.99 -5.39 -4.39 -1.84 -2.76 -0.07 -0.09 -0.31
Noncontrolling Interest		 0.00 11 41 39 29 - - - - 0.00 -0.04

Quarterly Balance Sheets for Veradigm

This table presents Veradigm's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022
Period end date 9/30/2022
Total Assets		 1,691
Total Current Assets		 811
Cash & Equivalents		 493
Restricted Cash		 1.31
Accounts Receivable		 169
Prepaid Expenses		 74
Other Current Assets		 65
Other Current Nonoperating Assets		 8.00
Plant, Property, & Equipment, net		 12
Total Noncurrent Assets		 868
Goodwill		 524
Intangible Assets		 223
Noncurrent Deferred & Refundable Income Taxes		 0.01
Other Noncurrent Operating Assets		 121
Other Noncurrent Nonoperating Assets		 0.00
Total Liabilities & Shareholders' Equity		 1,691
Total Liabilities		 514
Total Current Liabilities		 253
Accounts Payable		 13
Accrued Expenses		 83
Current Deferred Revenue		 99
Current Employee Benefit Liabilities		 34
Other Current Liabilities		 6.17
Other Current Nonoperating Liabilities		 19
Total Noncurrent Liabilities		 261
Long-Term Debt		 200
Noncurrent Deferred Revenue		 3.06
Noncurrent Deferred & Payable Income Tax Liabilities		 8.08
Other Noncurrent Operating Liabilities		 49
Other Noncurrent Nonoperating Liabilities		 0.00
Commitments & Contingencies		 0.00
Total Equity & Noncontrolling Interests		 1,177
Total Preferred & Common Equity		 1,177
Preferred Stock		 0.00
Total Common Equity		 1,177
Common Stock		 1,926
Retained Earnings		 753
Treasury Stock		 -1,499
Accumulated Other Comprehensive Income / (Loss)		 -3.89

Annual Metrics And Ratios for Veradigm

This table displays calculated financial ratios and metrics derived from Veradigm's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
DEI Shares Outstanding		 180,261,934.00 189,015,100.00 185,090,723.00 180,680,911.00 174,714,207.00 162,366,195.00 - - - 109,259,776.00 109,259,776.00
DEI Adjusted Shares Outstanding		 180,261,934.00 189,015,100.00 185,090,723.00 180,680,911.00 174,714,207.00 162,366,195.00 - - - 109,259,776.00 109,259,776.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.37 -0.01 -0.14 -1.09 2.08 -1.12 - - - 0.45 -2.67
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.35% 0.62% -0.02% 8.05% 0.00% 0.91% -65.94% 3.83% 1.83% 6.46% -5.04%
EBITDA Growth		 132.11% 43.61% 5.02% -17.36% 19.69% -121.44% 330.87% 164.82% -72.80% 42.24% -263.57%
EBIT Growth		 68.06% 188.66% 101.19% -82.53% 0.00% -6,151.05% 102.52% 2,795.16% -128.03% 163.48% -695.41%
NOPAT Growth		 69.29% -319.23% 158.30% -86.97% 0.00% 40.80% 107.96% 1,019.12% -130.50% 250.29% -577.89%
Net Income Growth		 36.12% 96.91% 247.37% -5,188.28% 0.00% -144.78% 481.19% -79.95% -161.95% 156.88% -692.92%
EPS Growth		 37.29% 97.30% -1,300.00% -678.57% 0.00% -153.14% 497.27% -76.89% -176.24% 153.25% -758.54%
Operating Cash Flow Growth		 27.79% 104.43% 27.14% 3.87% 0.00% -31.87% -324.10% 26.09% 250.83% -14.82% -120.12%
Free Cash Flow Firm Growth		 97.00% -2,792.16% -205.06% 206.93% 0.00% -193.54% 101.86% 2,596.64% -96.07% 89.70% -162.01%
Invested Capital Growth		 -1.04% 7.31% 42.47% -28.95% -100.00% 0.00% -1.60% -49.19% -6.40% -4.60% -13.15%
Revenue Q/Q Growth		 -0.73% 0.34% -5.72% -38.86% 0.00% 0.00% 0.00% 182.87% 2,164.57% 0.00% 0.00%
EBITDA Q/Q Growth		 22.02% 8.80% -10.08% -31.98% 0.00% -119.19% -51.46% 145.72% -77.58% 0.00% 0.00%
EBIT Q/Q Growth		 42.85% 181.56% -3.23% -84.64% 0.00% 0.00% 0.00% 3,283.13% -137.51% 0.00% 0.00%
NOPAT Q/Q Growth		 41.85% -1,843.86% -28.76% -84.02% 0.00% 0.00% 0.00% 454.77% -133.11% 0.00% 0.00%
Net Income Q/Q Growth		 21.72% 90.02% -81.66% 7.21% 0.00% 0.00% 0.00% -81.99% -242.60% 0.00% 0.00%
EPS Q/Q Growth		 22.92% 90.91% -1,300.00% 6.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 48.53% 17.67% 0.22% 8.71% 0.00% 128.07% -223.08% 75.99% -28.14% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 87.00% -103.22% -15.08% 811.78% 535.45% -238.39% -62.65% 128.48% -95.45% 0.00% 0.00%
Invested Capital Q/Q Growth		 -1.91% -1.60% 1.48% -32.10% -100.00% -19.96% -17.83% -47.84% -13.88% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 39.63% 41.88% 43.38% 42.25% 38.41% 37.38% 47.51% 48.91% 52.45% 54.56% 50.85%
EBITDA Margin		 9.86% 14.07% 14.78% 11.30% 11.64% -2.47% 16.76% 42.74% 11.42% 14.14% -24.36%
Operating Margin		 -2.84% 2.30% 4.89% 0.83% -10.41% -6.11% 1.43% 13.30% -4.61% 5.54% -32.75%
EBIT Margin		 -2.79% 2.46% 4.94% 0.80% 0.24% -14.61% 1.08% 30.14% -8.30% 5.44% -34.13%
Profit (Net Income) Margin		 -4.82% -0.15% 0.22% -10.29% 25.21% -11.18% 125.16% 24.17% -14.70% 7.86% -49.05%
Tax Burden Percent		 97.56% -360.70% 9.60% 81.13% -655.65% 64.81% -5,541.37% 88.50% 135.41% 81.75% 135.67%
Interest Burden Percent		 177.29% 1.67% 46.05% -1,587.35% -1,577.45% 118.09% -208.97% 90.62% 130.90% 176.54% 105.92%
Effective Tax Rate		 0.00% 460.70% 0.98% 0.00% 0.00% 0.00% 0.00% 18.98% 0.00% 17.75% 0.00%
Return on Invested Capital (ROIC)		 -1.52% -6.18% 2.87% 0.37% -12.08% -8.48% 0.34% 5.09% -2.38% 3.79% -19.86%
ROIC Less NNEP Spread (ROIC-NNEP)		 -9.25% 15.95% -5.16% -22.17% 280.05% -71.11% 441.26% -21.37% 14.81% -3.25% 41.54%
Return on Net Nonoperating Assets (RNNOA)		 -3.59% 6.02% -2.67% -9.85% 63.32% -8.94% 46.83% 4.13% -4.89% 0.91% -11.19%
Return on Equity (ROE)		 -5.11% -0.15% 0.20% -9.48% 51.24% -17.42% 47.17% 9.22% -7.27% 4.70% -31.05%
Cash Return on Invested Capital (CROIC)		 -0.47% -13.23% -32.16% 34.22% 187.92% -208.48% 1.95% 70.33% 4.23% 8.50% -5.78%
Operating Return on Assets (OROA)		 -1.51% 1.32% 2.10% 0.30% 0.19% -7.47% 0.20% 6.66% -2.56% 2.21% -13.87%
Return on Assets (ROA)		 -2.61% -0.08% 0.09% -3.82% 19.28% -5.72% 22.73% 5.34% -4.53% 3.20% -19.94%
Return on Common Equity (ROCE)		 -5.11% -0.15% 0.17% -6.86% 36.09% -17.24% 47.17% 9.22% -7.27% 4.70% -31.05%
Return on Equity Simple (ROE_SIMPLE)		 -5.17% -0.15% 0.25% -13.75% 0.00% -14.21% 41.77% 10.26% -8.50% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -27 -115 67 8.74 -118 -70 5.56 62 -19 29 -136
NOPAT Margin		 -1.99% -8.30% 4.84% 0.58% -7.29% -4.27% 1.00% 10.77% -3.23% 4.56% -22.92%
Net Nonoperating Expense Percent (NNEP)		 7.73% -22.13% 8.03% 22.54% -292.13% 62.63% -440.92% 26.46% -17.19% 7.04% -61.40%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - 0.30% 3.64% -1.56% 2.23% -13.22%
Cost of Revenue to Revenue		 60.37% 58.12% 56.62% 57.75% 61.59% 62.62% 52.49% 51.09% 47.55% 45.44% 49.15%
SG&A Expenses to Revenue		 26.03% 24.46% 24.13% 26.75% 26.75% 24.55% 27.99% 19.35% 28.77% 32.10% 45.32%
R&D to Revenue		 13.99% 13.33% 12.88% 13.51% 15.99% 15.03% 14.13% 14.57% 16.65% 15.49% 18.21%
Operating Expenses to Revenue		 42.47% 39.58% 38.50% 41.42% 48.82% 43.49% 46.09% 35.62% 57.06% 46.73% 82.76%
Earnings before Interest and Taxes (EBIT)		 -38 34 69 12 3.94 -239 6.01 174 -49 34 -203
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 136 195 205 169 188 -40 93 247 67 89 -145
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.79 2.43 1.54 2.35 0.00 1.24 1.21 1.58 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 9.55 3.40 0.00 0.00 0.00
Price to Revenue (P/Rev)		 1.67 2.47 1.37 1.76 1.02 0.98 3.64 3.71 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 4.54 0.00 2.91 15.36 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 22.02% 0.00% 34.42% 6.51% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.56 2.05 1.24 2.00 0.00 1.44 1.02 2.87 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 2.04 2.84 2.46 2.61 1.02 1.45 2.97 4.09 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 20.68 20.22 16.67 23.09 8.77 0.00 17.73 9.56 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 115.76 49.83 326.51 418.88 0.00 274.86 13.56 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 50.94 447.31 0.00 0.00 297.26 37.93 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 27.14 18.64 12.70 13.99 24.33 51.34 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 4.86 0.90 0.00 51.89 2.75 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.44 0.44 0.80 0.59 0.00 0.71 0.10 0.26 0.20 0.19 0.28
Long-Term Debt to Equity		 0.42 0.43 0.79 0.57 0.00 0.43 0.10 0.26 0.20 0.00 0.09
Financial Leverage		 0.39 0.38 0.52 0.44 0.23 0.13 0.11 -0.19 -0.33 -0.28 -0.27
Leverage Ratio		 1.95 1.90 2.12 2.48 2.66 2.23 2.07 1.73 1.60 1.47 1.56
Compound Leverage Factor		 3.46 0.03 0.97 -39.35 -41.93 2.63 -4.34 1.57 2.10 2.60 1.65
Debt to Total Capital		 30.62% 30.60% 44.49% 37.08% 0.00% 41.60% 9.14% 20.47% 16.45% 16.03% 22.01%
Short-Term Debt to Total Capital		 1.49% 0.62% 0.89% 1.14% 0.00% 16.56% 0.00% 0.00% 0.00% 16.03% 15.01%
Long-Term Debt to Total Capital		 29.13% 29.98% 43.60% 35.94% 0.00% 25.04% 9.14% 20.47% 16.45% 0.00% 7.01%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.55% 14.32% 18.61% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 69.38% 68.86% 41.19% 44.31% 0.00% 58.40% 90.86% 79.53% 83.55% 83.97% 77.99%
Debt to EBITDA		 4.17 3.21 6.50 5.54 0.00 -22.68 1.80 1.42 2.98 2.32 -1.57
Net Debt to EBITDA		 3.77 2.61 5.30 4.77 0.00 -19.27 -3.97 0.87 -3.69 -3.84 1.15
Long-Term Debt to EBITDA		 3.97 3.14 6.37 5.37 0.00 -13.65 1.80 1.42 2.98 0.00 -0.50
Debt to NOPAT		 -20.66 -5.44 19.86 107.32 0.00 -13.12 30.15 5.63 -10.56 7.20 -1.67
Net Debt to NOPAT		 -18.67 -4.42 16.19 92.33 0.00 -11.15 -66.55 3.46 13.05 -11.92 1.22
Long-Term Debt to NOPAT		 -19.66 -5.33 19.46 104.03 0.00 -7.90 30.15 5.63 -10.56 0.00 -0.53
Altman Z-Score		 1.55 2.10 0.86 0.84 0.00 0.60 1.56 2.37 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.41% 14.27% 27.64% 29.58% 1.02% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.93 1.05 0.91 0.96 0.00 0.69 1.23 1.33 2.95 1.57 1.29
Quick Ratio		 0.74 0.87 0.75 0.69 0.00 0.46 0.94 0.52 2.46 1.25 0.95
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -8.52 -246 -752 804 1,834 -1,715 32 859 34 64 -40
Operating Cash Flow to CapEx		 154.44% 313.05% 216.44% 177.97% 50.74% 38.62% -228.39% -185.13% 358.15% 338.81% -66.35%
Free Cash Flow to Firm to Interest Expense		 -0.29 -7.85 -25.50 21.41 36.01 -39.73 0.93 66.44 5.31 12.08 -1.21
Operating Cash Flow to Interest Expense		 3.53 6.74 9.13 7.44 1.33 1.07 -3.02 -5.93 18.19 18.80 -0.61
Operating Cash Flow Less CapEx to Interest Expense		 1.25 4.59 4.91 3.26 -1.29 -1.70 -4.34 -9.13 13.11 13.25 -1.54
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.54 0.54 0.43 0.37 0.76 0.51 0.18 0.22 0.31 0.41 0.41
Accounts Receivable Turnover		 4.27 4.20 3.78 3.34 0.00 3.67 1.44 2.47 4.92 5.44 5.43
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 8.62 10.21 10.10 10.54 0.00 15.56 6.95 12.85 43.24 0.00 0.00
Accounts Payable Turnover		 11.57 12.32 8.43 8.16 0.00 11.62 4.21 15.49 16.94 10.92 11.19
Days Sales Outstanding (DSO)		 85.45 86.81 96.52 109.39 0.00 99.45 253.27 147.61 74.13 67.14 67.18
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 31.54 29.63 43.29 44.71 0.00 31.42 86.74 23.56 21.55 33.43 32.62
Cash Conversion Cycle (CCC)		 53.90 57.18 53.23 64.68 0.00 68.04 166.53 124.06 52.58 33.71 34.56
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,796 1,928 2,747 1,951 0.00 1,645 1,619 823 770 735 638
Invested Capital Turnover		 0.76 0.74 0.59 0.64 1.66 1.98 0.34 0.47 0.74 0.83 0.87
Increase / (Decrease) in Invested Capital		 -19 131 819 -795 -1,951 1,645 -26 -796 -53 -35 -97
Enterprise Value (EV)		 2,809 3,944 3,415 3,909 1,652 2,375 1,652 2,359 0.00 0.00 0.00
Market Capitalization		 2,297 3,424 1,901 2,631 1,652 1,597 2,022 2,144 0.00 0.00 0.00
Book Value per Share		 $7.12 $7.45 $6.66 $6.20 $0.00 $7.92 $10.55 $11.10 $9.31 $9.83 $7.36
Tangible Book Value per Share		 ($2.25) ($1.31) ($8.63) ($4.44) $0.00 ($1.72) $1.34 $5.15 $2.93 $3.64 $1.21
Total Capital		 1,851 2,045 2,992 2,529 0.00 2,201 1,834 1,710 1,218 1,280 1,031
Total Debt		 567 626 1,331 938 0.00 915 168 350 200 205 227
Total Long-Term Debt		 539 613 1,305 909 0.00 551 168 350 200 0.00 72
Net Debt		 512 509 1,086 807 0.00 778 -370 215 -248 -340 -166
Capital Expenditures (CapEx)		 67 68 124 157 134 120 45 41 32 29 30
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -60 -79 -133 -135 0.00 -143 -319 26 1.44 12 -16
Debt-free Net Working Capital (DFNWC)		 -6.69 38 -36 -3.73 0.00 -4.96 218 161 449 458 278
Net Working Capital (NWC)		 -34 25 -63 -33 0.00 -369 218 161 449 253 124
Net Nonoperating Expense (NNE)		 39 -113 64 163 -526 113 -690 -77 67 -21 155
Net Nonoperating Obligations (NNO)		 512 509 1,086 360 0.00 360 -47 -538 -248 -340 -166
Total Depreciation and Amortization (D&A)		 174 161 136 157 184 198 87 73 116 54 58
Debt-free, Cash-free Net Working Capital to Revenue		 -4.34% -5.69% -9.57% -9.00% 0.00% -8.73% -57.37% 4.47% 0.24% 1.88% -2.65%
Debt-free Net Working Capital to Revenue		 -0.49% 2.74% -2.60% -0.25% 0.00% -0.30% 39.28% 27.85% 76.42% 73.23% 46.85%
Net Working Capital to Revenue		 -2.48% 1.83% -4.53% -2.17% 0.00% -22.63% 39.28% 27.85% 76.42% 40.45% 20.82%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.37) ($0.01) ($0.14) ($1.09) $2.07 ($1.10) $4.40 $1.03 ($0.77) $0.00 ($2.70)
Adjusted Weighted Average Basic Shares Outstanding		 180.52M 189.34M 180.51M 180.85M 171.33M 162.70M 140.03M 116.21M 0.00 0.00 0.00
Adjusted Diluted Earnings per Share		 ($0.37) ($0.01) ($0.14) ($1.09) $2.04 ($1.10) $4.40 $0.97 ($0.77) $0.00 ($2.70)
Adjusted Weighted Average Diluted Shares Outstanding		 180.52M 189.34M 180.51M 180.85M 171.33M 162.70M 140.03M 116.21M 0.00 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 ($0.37) ($0.01) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 180.52M 189.34M 180.51M 180.85M 171.33M 162.70M 140.03M 116.21M 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 -26 23 72 8.74 -68 -44 13 63 -14 17 -64
Normalized NOPAT Margin		 -1.87% 1.69% 5.17% 0.58% -4.19% -2.71% 2.28% 10.85% -2.33% 2.70% -10.77%
Pre Tax Income Margin		 -4.94% 0.04% 2.28% -12.69% -3.84% -17.26% -2.26% 27.31% -10.86% 9.61% -36.16%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -1.31 1.09 2.33 0.32 0.08 -5.53 0.18 13.46 -7.68 6.44 -6.21
NOPAT to Interest Expense		 -0.94 -3.66 2.27 0.23 -2.32 -1.62 0.16 4.81 -2.99 5.39 -4.17
EBIT Less CapEx to Interest Expense		 -3.60 -1.07 -1.89 -3.86 -2.55 -8.30 -1.15 10.26 -12.76 0.89 -7.13
NOPAT Less CapEx to Interest Expense		 -3.22 -5.82 -1.94 -3.95 -4.94 -4.39 -1.16 1.61 -8.06 -0.16 -5.09
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% -0.83% 3.04% -37.51% 0.63% 1.72% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 4,001.35% -8.67% 37.11% -98.54% 48.63% 300.82% -271.13% 0.00% 0.00%

Quarterly Metrics And Ratios for Veradigm

This table displays calculated financial ratios and metrics derived from Veradigm's official financial filings.

Metric Q3 2022 Q4 2022
Period end date 9/30/2022 12/31/2022
Growth Metrics		 - -
Revenue Growth		 5.01% -9.74%
EBITDA Growth		 -14.70% -104.14%
EBIT Growth		 -14.95% -178.16%
NOPAT Growth		 -19.26% -235.70%
Net Income Growth		 -10.21% -164.74%
EPS Growth		 0.00% -176.47%
Operating Cash Flow Growth		 -49.65% -69.00%
Free Cash Flow Firm Growth		 70.55% -98.14%
Invested Capital Growth		 -43.31% -6.40%
Revenue Q/Q Growth		 0.68% -6.19%
EBITDA Q/Q Growth		 263.24% -112.73%
EBIT Q/Q Growth		 927.06% -395.60%
NOPAT Q/Q Growth		 393.84% -438.80%
Net Income Q/Q Growth		 122.69% -511.76%
EPS Q/Q Growth		 122.22% -533.33%
Operating Cash Flow Q/Q Growth		 1,821.16% -29.66%
Free Cash Flow Firm Q/Q Growth		 2.50% -97.79%
Invested Capital Q/Q Growth		 -1.22% -13.88%
Profitability Metrics		 - -
Gross Margin		 54.92% 50.53%
EBITDA Margin		 26.64% -3.62%
Operating Margin		 16.46% -37.41%
EBIT Margin		 17.55% -55.29%
Profit (Net Income) Margin		 9.56% -41.97%
Tax Burden Percent		 58.60% 68.46%
Interest Burden Percent		 93.01% 110.89%
Effective Tax Rate		 55.94% 0.00%
Return on Invested Capital (ROIC)		 0.15% -19.34%
ROIC Less NNEP Spread (ROIC-NNEP)		 -5.49% -13.61%
Return on Net Nonoperating Assets (RNNOA)		 0.26% 4.49%
Return on Equity (ROE)		 0.42% -14.84%
Cash Return on Invested Capital (CROIC)		 59.92% 4.23%
Operating Return on Assets (OROA)		 0.22% -17.04%
Return on Assets (ROA)		 0.12% -12.94%
Return on Common Equity (ROCE)		 0.42% -14.84%
Return on Equity Simple (ROE_SIMPLE)		 5.15% 0.00%
Net Operating Profit after Tax (NOPAT)		 11 -37
NOPAT Margin		 7.25% -26.19%
Net Nonoperating Expense Percent (NNEP)		 5.65% -5.73%
Return On Investment Capital (ROIC_SIMPLE)		 - -3.06%
Cost of Revenue to Revenue		 45.08% 49.47%
SG&A Expenses to Revenue		 21.40% 24.92%
R&D to Revenue		 15.59% 19.67%
Operating Expenses to Revenue		 38.46% 87.94%
Earnings before Interest and Taxes (EBIT)		 27 -79
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 40 -5.15
Valuation Ratios		 - -
Price to Book Value (P/BV)		 1.41 0.00
Price to Tangible Book Value (P/TBV)		 3.87 0.00
Price to Revenue (P/Rev)		 64.08 0.00
Price to Earnings (P/E)		 17.79 0.00
Dividend Yield		 0.00% 0.00%
Earnings Yield		 5.62% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.53 0.00
Enterprise Value to Revenue (EV/Rev)		 52.78 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 4.58 0.00
Enterprise Value to EBIT (EV/EBIT)		 10.54 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 23.92 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 8.52 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 1.85 0.00
Leverage & Solvency		 - -
Debt to Equity		 0.17 0.20
Long-Term Debt to Equity		 0.17 0.20
Financial Leverage		 -0.05 -0.33
Leverage Ratio		 1.61 1.60
Compound Leverage Factor		 1.50 1.78
Debt to Total Capital		 14.54% 16.45%
Short-Term Debt to Total Capital		 0.00% 0.00%
Long-Term Debt to Total Capital		 14.54% 16.45%
Preferred Equity to Total Capital		 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00%
Common Equity to Total Capital		 85.46% 83.55%
Debt to EBITDA		 0.67 2.98
Net Debt to EBITDA		 -0.98 -3.69
Long-Term Debt to EBITDA		 0.67 2.98
Debt to NOPAT		 3.50 -10.56
Net Debt to NOPAT		 -5.12 13.05
Long-Term Debt to NOPAT		 3.50 -10.56
Altman Z-Score		 3.03 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00%
Liquidity Ratios		 - -
Current Ratio		 3.20 2.95
Quick Ratio		 2.61 2.46
Cash Flow Metrics		 - -
Free Cash Flow to Firm (FCFF)		 694 15
Operating Cash Flow to CapEx		 344.32% 473.23%
Free Cash Flow to Firm to Interest Expense		 557.08 14.16
Operating Cash Flow to Interest Expense		 22.59 18.24
Operating Cash Flow Less CapEx to Interest Expense		 16.03 14.39
Efficiency Ratios		 - -
Asset Turnover		 0.01 0.31
Accounts Receivable Turnover		 0.10 4.92
Inventory Turnover		 0.00 0.00
Fixed Asset Turnover		 0.79 43.24
Accounts Payable Turnover		 102.15 16.94
Days Sales Outstanding (DSO)		 3,584.16 74.13
Days Inventory Outstanding (DIO)		 0.00 0.00
Days Payable Outstanding (DPO)		 3.57 21.55
Cash Conversion Cycle (CCC)		 3,580.59 52.58
Capital & Investment Metrics		 - -
Invested Capital		 894 770
Invested Capital Turnover		 0.02 0.74
Increase / (Decrease) in Invested Capital		 -683 -53
Enterprise Value (EV)		 1,370 0.00
Market Capitalization		 1,664 0.00
Book Value per Share		 $10.62 $9.31
Tangible Book Value per Share		 $3.88 $2.93
Total Capital		 1,377 1,218
Total Debt		 200 200
Total Long-Term Debt		 200 200
Net Debt		 -294 -248
Capital Expenditures (CapEx)		 8.17 4.18
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 64 1.44
Debt-free Net Working Capital (DFNWC)		 558 449
Net Working Capital (NWC)		 558 449
Net Nonoperating Expense (NNE)		 -3.51 22
Net Nonoperating Obligations (NNO)		 -283 -248
Total Depreciation and Amortization (D&A)		 14 74
Debt-free, Cash-free Net Working Capital to Revenue		 245.61% 0.24%
Debt-free Net Working Capital to Revenue		 2,147.73% 76.42%
Net Working Capital to Revenue		 2,147.73% 76.42%
Earnings Adjustments		 - -
Adjusted Basic Earnings per Share		 $0.13 ($0.54)
Adjusted Weighted Average Basic Shares Outstanding		 109.26M 0.00
Adjusted Diluted Earnings per Share		 $0.12 ($0.52)
Adjusted Weighted Average Diluted Shares Outstanding		 109.26M 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 109.26M 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 18 -37
Normalized NOPAT Margin		 11.52% -26.19%
Pre Tax Income Margin		 16.32% -61.31%
Debt Service Ratios		 - -
EBIT to Interest Expense		 21.39 -72.62
NOPAT to Interest Expense		 8.84 -34.40
EBIT Less CapEx to Interest Expense		 14.83 -76.48
NOPAT Less CapEx to Interest Expense		 2.28 -38.26
Payout Ratios		 - -
Dividend Payout Ratio		 0.00% 0.00%
Augmented Payout Ratio		 470.89% -271.13%

Financials Breakdown Chart

Key Financial Trends

Veradigm (NASDAQ: MDRX) showed a sharp reversal in performance from Q3 2022 to Q4 2022. Revenue declined modestly, profitability swung from a gain to a loss, and cash flow weakened materially in the quarter. At the same time, the company still generated positive operating cash flow, which suggests the core business remained cash-generative despite the bottom-line loss.

What stood out most:

  • Q4 operating cash flow remained positive at $19.8 million, showing the business still produced cash from operations.
  • Gross profit in Q4 was still substantial at $72.0 million, with gross margin around 50% of revenue.
  • The company had a strong cash position on the balance sheet at the end of Q3 2022, with $492.6 million in cash and equivalents.
  • Despite the Q4 loss, Veradigm continued to invest in the business through acquisitions and capital spending, which may support longer-term growth.
  • Q4 revenue of $142.5 million was only modestly below Q3 revenue of $151.9 million, indicating no dramatic collapse in sales.
  • The company reported a sizable amount of intangible assets and goodwill, reflecting prior acquisitions and a strategy that relies partly on inorganic growth.
  • Basic and diluted EPS in Q4 were both negative, at $(0.54) and $(0.52), respectively.
  • Consolidated net income fell from a profit of $14.5 million in Q3 to a loss of $59.8 million in Q4.
  • Operating income deteriorated sharply, moving from a profit of $25.0 million in Q3 to a loss of $53.3 million in Q4.
  • Q4 cash from financing activities was a large outflow of $57.5 million, driven mainly by $57.4 million in common equity repurchases.

Quarter-over-quarter trend analysis:

On the income statement, Veradigm’s Q4 revenue declined by about 6% from Q3, but the bigger issue was expense pressure. Total operating expenses jumped to $125.3 million in Q4 from $58.4 million in Q3, pushing the company from a healthy operating profit to a significant operating loss. Amortization expense was especially notable at $54.2 million in Q4, which appears to have been a major factor in the weaker results.

On the cash flow statement, the business remained operationally positive, but the quarter was weighed down by investing and financing outflows. Veradigm used $18.6 million in investing activities and $57.5 million in financing activities, resulting in a $55.1 million decline in cash and equivalents for the quarter.

Balance sheet context:

The most recent balance sheet provided is for Q3 2022, and it shows a company with a large cash cushion and substantial assets. Total assets were $1.69 billion against total liabilities of $513.6 million, leaving book equity of $1.18 billion. However, the balance sheet also included $200.3 million of long-term debt and a large amount of goodwill and intangible assets, which are worth watching if profitability remains weak.

Bottom line: Veradigm entered Q4 with a strong balance sheet and had positive operating cash flow, but the quarter itself was a clear setback. Investors will likely want to see whether the Q4 loss was driven by one-time charges and whether the company can restore operating profitability while preserving cash.

07/03/26 01:47 AM ETAI Generated. May Contain Errors.

Veradigm Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Veradigm's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

Veradigm's net income appears to be on a downward trend, with a most recent value of -$291.58 million in 2024, rising from -$66.45 million in 2014. The previous period was $49.18 million in 2023.

Veradigm's total operating income in 2024 was -$194.66 million, based on the following breakdown:
  • Total Gross Profit: $302.25 million
  • Total Operating Expenses: $491.91 million

Over the last 10 years, Veradigm's total revenue changed from $1.38 billion in 2014 to $594.41 million in 2024, a change of -56.9%.

Veradigm's total liabilities were at $548.30 million at the end of 2024, a 10.0% increase from 2023, and a 53.5% decrease since 2014.

In the past 10 years, Veradigm's cash and equivalents has ranged from $53.17 million in 2014 to $531.10 million in 2020, and is currently $294.25 million as of their latest financial filing in 2024.

Over the last 10 years, Veradigm's book value per share changed from 7.12 in 2014 to 7.36 in 2024, a change of 3.3%.


Related Companies

Financial statements for NASDAQ:MDRX last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel